AXL and viral infectious disease: Various studies have proposed the tyrosine kinase receptor anexelekto (AXL), a member of the TAM (Tyro3, AXL, Mer) family, as the ZIKV entry point, while its inhibition reduces viral infection and NSC growth impairment [59,60,61].